	The effect of immunonutritional support in patients undergoing surgery and adjuvant chemotherapy for lung cancer. Support Care Cancer Kececi Ozgur G, Akcam TI, Dal SB, Tekneci AK, Gursoy P, Ergonul AG, Turhan K, Cagirici U, Cakan A. PMID: 41975170 [PubMed - indexed for MEDLINE]
	Chinese Herbal Medicine Is Associated With Improved Survival in Patients With Advanced Lung Cancer Receiving Standard Treatment: A Nationwide Population-Based Propensity Score Matching Study. Integr Cancer Ther Hsiao KY, Chang WS, Ou SC, Yao HR, Chang DC, Shia BC, Chen MC, Hsieh MC. PMID: 41974648 [PubMed - indexed for MEDLINE]
	Bacterial effectors disrupt host DNA: Linking sputum microbiome profiles to chromosomal aberrations in leukocytes of lung cancer patients and healthy controls. Mutat Res Genet Toxicol Environ Mutagen Druzhinin VG, Baranova ED, Demenkov PS, Matskova LV, Larionov AV, Zhivotovskiy AS, Yuzhalin AE. PMID: 41974522 [PubMed - indexed for MEDLINE]
	Albumin-myosteatosis gauge as predictor of survival time in patients with lung cancer treated with immune checkpoint inhibitors. Clin Nutr ESPEN Wei L, Tian M, Han Q, Wang W, Jin X, Xu X. PMID: 41974370 [PubMed - as supplied by publisher]
	Reforming the delivery of smoking cessation: a distributional cost-effectiveness analysis of providing smoking cessation as part of targeted lung cancer screening. J Med Econ Fewster H, Nuttall P, Evison M, Holmes H, Malcolm R. PMID: 41973660 [PubMed - indexed for MEDLINE]
	Lung Cancer Diagnosis Rates in Early Detection Programs in the Mississippi Delta. JAMA Netw Open Liao W, Tye S, Goss J, Fehnel C, Ray M, Osarogiagbon RU. PMID: 41973426 [PubMed - indexed for MEDLINE]
	RETRACTION: AKIP1 Expression in Tumor Tissue as a New Biomarker for Disease Monitoring and Prognosis in Non-Small Cell Lung Cancer: Results of a Retrospective Study. J Clin Lab Anal PMID: 41972948 [PubMed - as supplied by publisher]
	Diagnostic and Therapeutic Applications of Exosomes in Lung Cancer. Cells Moholkar DN, Kandimalla R, Wallen M, Yaddanapudi K, Gupta R, Aqil F. PMID: 41972720 [PubMed - indexed for MEDLINE]
	Efficacy of zero echo time pulmonary MRI for RECIST 1.1 response classification in lung cancer: a prospective study. Quant Imaging Med Surg Li Z, Liu W, Zhang L, Li L, Yin H, Duan J, Xie B, Wang K, Yuan Z, Yan R. PMID: 41972083 [PubMed]
	Translating Liquid Biopsy into Practice- The Promise and Challenges of Circulating Tumor Cells in Ovarian and Lung Cancer Management. Biomark Insights Mustafa N, Tanisha MH, Tasneem F, Siddique MA, Ahmed Z, Chowdhury NM, Rabbi F. PMID: 41971711 [PubMed]
	Radiomics-machine learning model for predicting invasiveness of subcentimeter subsolid lung adenocarcinoma: a validation study with external cohort and SHAP interpretability. Front Oncol Feng W, Chang R, Li T, Wang X, Gao Z, Yang X, Yin Y, Zuo Y. PMID: 41971431 [PubMed]
	Experiences of psychosomatic symptoms and self-management strategies among patients with advanced lung cancer undergoing chemotherapy: a qualitative study based on symptom management theory. Front Public Health Xiong B, Jin C, Zhang Z, Xu R. PMID: 41971284 [PubMed - indexed for MEDLINE]
	Lung metastasis with primary conjunctival mucoepidermoid carcinoma. Rom J Ophthalmol Calleja-Casado F, Lanuza-García A, Ortega-Prades G, Maugard-Tepper SA, Samper AD. PMID: 41971202 [PubMed - indexed for MEDLINE]
	Natural compounds for non-small cell lung cancer treatment: focus on the EGFR signaling pathway. Front Pharmacol Ye B, Xiao Q. PMID: 41971100 [PubMed]
	Risk Factors for Venous Thromboembolism in Advanced Non-Small Cell Lung Cancer: A Nationwide Administrative Database Study. Circ Rep Kimura T, Yamashita Y, Ihara Y, Mizutani M, Kawai R, Shintani A. PMID: 41970474 [PubMed]
	Multidimensional biomarker profiling of bronchoalveolar lavage fluid for diagnostic and prognostic evaluation of lung cancer: a retrospective observational study. Front Med (Lausanne) Wang Y, Huang J, Xie X, Li S, Fu Q. PMID: 41970393 [PubMed]
	Development and validation of an inflammatory-immune-nutritional integrated scoring system: a novel strategy for predicting postoperative survival in non-small cell lung cancer. PeerJ Huang Q, Xu N, Xu K. PMID: 41970259 [PubMed - indexed for MEDLINE]
	Nanovaccines for lung cancer: Platforms, mechanistic insights, and translational challenges. Chin Med J Pulm Crit Care Med Hosseinalizadeh H, Ge F, Davari M, Liu X, Tian L, Yu J. PMID: 41970200 [PubMed]
	Immunotherapy for patients with EGFR-TKI-resistant non-small-cell lung cancer: Potential mechanisms, efficacy predictors, and therapeutic integration. Chin Med J Pulm Crit Care Med Wu X, Shi Y, Wang D, Liu B, Zhang Y, Zhang L, Qian F, Zhang W. PMID: 41970199 [PubMed]
	Progression of interstitial lung abnormalities and its impact on mortality in patients with lung cancer resection. Chin Med J Pulm Crit Care Med Mao R, Zhang H, Chang Q, Teng Y, Ni Y, Chen J, Li M, Xu N, Zhang H, Chen Y, Sun J, Chung KF, Renzoni EA, Lu Y, Dai H, Li F. PMID: 41970198 [PubMed]

Articles 1 - 20 / 158820

Page 1 of 7941



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy